IMR Press / EJGO / Volume 19 / Issue 2 / pii/1998143

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Borderline ovarian tumours: retrospective analysis of twenty-one cases

Show Less
1 Doku? Eylül University, Faculty of Medicine, Department of Obstetrics and Gynecology, Izmir, Turkey
Eur. J. Gynaecol. Oncol. 1998, 19(2), 182–185;
Published: 10 April 1998
Abstract

Twenty-one borderline ovarian tumour cases, diagnosed and treated in our oncology section between 1986 and 1996, were retro­spectively analysed. Thirty-three percent of the cases had serous tumours and the rest (66.6%) were mucinous, 57.1% of the mucinous tumours were the intestinal type and the remaining 42.9% were the endocervical type. When all the cases were analysed, the average age was 45.4 ± 18.6 years, the average follow-up period was 5.5 ± 2.6 years. The preoperative average CA125 level was 55.1 ± 51.9 U/mL, and for CA19.9 it was 48.2 ± 47.8 U/mL. Of the patients 85.7% were stage I and 14.3% state III. There were not any significant differences between the serous, intestinal-type mucinous and endometroid-type mucinous tumours regarding tumour volumes (p > 0.05). When serous and mucinous tumours were compared according to the tumour markers, CA125 levels were significantly higher in the serous tumours (p = 0.04) and CA19.9 levels were significantly higher in the mucinous tumours (p = 0.02). All of the patients are under our follow-up and are in remission, except one, who died in the third year of the treatment because of chronic renal failure unrelated to the ovarian pathology.

Keywords
Borderline ovarian tumours
Serous
Mucinous
CA125
CA19.9
Share
Back to top